nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—NQO1—Carboplatin—bone cancer	0.172	0.22	CbGbCtD
Menadione—NQO1—Cisplatin—bone cancer	0.147	0.188	CbGbCtD
Menadione—NQO1—Doxorubicin—bone cancer	0.0983	0.126	CbGbCtD
Menadione—XDH—Carboplatin—bone cancer	0.0898	0.115	CbGbCtD
Menadione—MTHFR—Methotrexate—bone cancer	0.0867	0.111	CbGbCtD
Menadione—XDH—Cisplatin—bone cancer	0.0767	0.0984	CbGbCtD
Menadione—AOX1—Methotrexate—bone cancer	0.0576	0.0739	CbGbCtD
Menadione—XDH—Doxorubicin—bone cancer	0.0514	0.066	CbGbCtD
Menadione—BGLAP—mandible—bone cancer	0.0105	0.0962	CbGeAlD
Menadione—BGLAP—jaw skeleton—bone cancer	0.00895	0.0818	CbGeAlD
Menadione—BGLAP—periosteum—bone cancer	0.00676	0.0618	CbGeAlD
Menadione—F2—knee—bone cancer	0.00611	0.0558	CbGeAlD
Menadione—BGLAP—vertebral column—bone cancer	0.0056	0.0512	CbGeAlD
Menadione—BGLAP—skull—bone cancer	0.00555	0.0508	CbGeAlD
Menadione—BGLAP—leg—bone cancer	0.00539	0.0492	CbGeAlD
Menadione—BGLAP—forelimb—bone cancer	0.00535	0.0489	CbGeAlD
Menadione—BGLAP—hindlimb—bone cancer	0.00481	0.044	CbGeAlD
Menadione—BGLAP—cartilage tissue—bone cancer	0.00474	0.0433	CbGeAlD
Menadione—BGLAP—arm—bone cancer	0.0046	0.042	CbGeAlD
Menadione—BGLAP—appendage—bone cancer	0.00413	0.0377	CbGeAlD
Menadione—F2—vertebral column—bone cancer	0.00348	0.0318	CbGeAlD
Menadione—F2—leg—bone cancer	0.00335	0.0306	CbGeAlD
Menadione—F2—forelimb—bone cancer	0.00333	0.0304	CbGeAlD
Menadione—F2—hindlimb—bone cancer	0.00299	0.0273	CbGeAlD
Menadione—F2—appendage—bone cancer	0.00257	0.0235	CbGeAlD
Menadione—F7—connective tissue—bone cancer	0.00202	0.0184	CbGeAlD
Menadione—F9—connective tissue—bone cancer	0.00193	0.0176	CbGeAlD
Menadione—PROC—bone marrow—bone cancer	0.00153	0.014	CbGeAlD
Menadione—VKORC1L1—tendon—bone cancer	0.00131	0.0119	CbGeAlD
Menadione—F9—spinal cord—bone cancer	0.00128	0.0117	CbGeAlD
Menadione—BGLAP—connective tissue—bone cancer	0.00118	0.0108	CbGeAlD
Menadione—PROS1—connective tissue—bone cancer	0.00109	0.00998	CbGeAlD
Menadione—GGCX—tendon—bone cancer	0.00079	0.00722	CbGeAlD
Menadione—BGLAP—bone marrow—bone cancer	0.000784	0.00717	CbGeAlD
Menadione—PROS1—tendon—bone cancer	0.000751	0.00686	CbGeAlD
Menadione—F2—connective tissue—bone cancer	0.000732	0.00669	CbGeAlD
Menadione—PROS1—bone marrow—bone cancer	0.000727	0.00665	CbGeAlD
Menadione—PROS1—spinal cord—bone cancer	0.000724	0.00662	CbGeAlD
Menadione—F10—tendon—bone cancer	0.000707	0.00646	CbGeAlD
Menadione—NQO1—connective tissue—bone cancer	0.000611	0.00558	CbGeAlD
Menadione—NQO2—tendon—bone cancer	0.000502	0.00458	CbGeAlD
Menadione—F2—bone marrow—bone cancer	0.000488	0.00446	CbGeAlD
Menadione—NQO2—bone marrow—bone cancer	0.000486	0.00444	CbGeAlD
Menadione—F2—spinal cord—bone cancer	0.000486	0.00444	CbGeAlD
Menadione—NQO2—spinal cord—bone cancer	0.000484	0.00442	CbGeAlD
Menadione—MAOB—connective tissue—bone cancer	0.000432	0.00395	CbGeAlD
Menadione—NQO1—tendon—bone cancer	0.00042	0.00384	CbGeAlD
Menadione—NQO1—spinal cord—bone cancer	0.000405	0.0037	CbGeAlD
Menadione—Thalidomide—PTGS2—bone cancer	0.000398	1	CrCbGaD
Menadione—AOX1—tendon—bone cancer	0.000385	0.00352	CbGeAlD
Menadione—MAOB—tendon—bone cancer	0.000297	0.00271	CbGeAlD
Menadione—MAOB—spinal cord—bone cancer	0.000286	0.00262	CbGeAlD
Menadione—F7—Hemostasis—GNA11—bone cancer	0.000215	0.00193	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.000213	0.00192	CbGpPWpGaD
Menadione—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000213	0.00192	CbGpPWpGaD
Menadione—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000213	0.00192	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—EIF2S1—bone cancer	0.000208	0.00187	CbGpPWpGaD
Menadione—BGLAP—Glucocorticoid receptor regulatory network—TP53—bone cancer	0.000207	0.00186	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—TUBB2A—bone cancer	0.000206	0.00185	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—MOGS—bone cancer	0.000204	0.00184	CbGpPWpGaD
Menadione—CYP1A1—Tryptophan metabolism—CYP3A4—bone cancer	0.000201	0.00181	CbGpPWpGaD
Menadione—PROC—Hemostasis—SPARC—bone cancer	0.000197	0.00177	CbGpPWpGaD
Menadione—F7—Hemostasis—IL3—bone cancer	0.000195	0.00175	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—EIF2S1—bone cancer	0.000193	0.00174	CbGpPWpGaD
Menadione—MAOB—Biological oxidations—CYP3A4—bone cancer	0.000192	0.00173	CbGpPWpGaD
Menadione—CYP2E1—tendon—bone cancer	0.00019	0.00174	CbGeAlD
Menadione—CYP2E1—spinal cord—bone cancer	0.000183	0.00168	CbGeAlD
Menadione—F10—Metabolism of proteins—TUBB4B—bone cancer	0.000182	0.00164	CbGpPWpGaD
Menadione—PROC—Hemostasis—GNA11—bone cancer	0.00018	0.00162	CbGpPWpGaD
Menadione—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000178	0.00161	CbGpPWpGaD
Menadione—MTHFR—Selenium Micronutrient Network—PTGS2—bone cancer	0.000177	0.00159	CbGpPWpGaD
Menadione—CYP2A6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000177	0.00159	CbGpPWpGaD
Menadione—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—bone cancer	0.000174	0.00157	CbGpPWpGaD
Menadione—PROS1—Hemostasis—SPARC—bone cancer	0.000174	0.00157	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—EIF2S1—bone cancer	0.000172	0.00155	CbGpPWpGaD
Menadione—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000172	0.00155	CbGpPWpGaD
Menadione—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00017	0.00153	CbGpPWpGaD
Menadione—F2—G alpha (q) signalling events—GNA11—bone cancer	0.000166	0.00149	CbGpPWpGaD
Menadione—MAOB—Biological oxidations—GSTP1—bone cancer	0.000165	0.00148	CbGpPWpGaD
Menadione—PROC—Hemostasis—IL3—bone cancer	0.000163	0.00147	CbGpPWpGaD
Menadione—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000163	0.00147	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—JUN—bone cancer	0.000163	0.00147	CbGpPWpGaD
Menadione—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000162	0.00146	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—EIF2S1—bone cancer	0.000162	0.00146	CbGpPWpGaD
Menadione—XDH—Selenium Micronutrient Network—PTGS2—bone cancer	0.00016	0.00145	CbGpPWpGaD
Menadione—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00016	0.00144	CbGpPWpGaD
Menadione—PROS1—Hemostasis—GNA11—bone cancer	0.000159	0.00143	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000158	0.00143	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—TUBB2A—bone cancer	0.000157	0.00141	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—GRM4—bone cancer	0.000149	0.00135	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000148	0.00133	CbGpPWpGaD
Menadione—F9—Hemostasis—PLAU—bone cancer	0.000145	0.00131	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000145	0.00131	CbGpPWpGaD
Menadione—PROS1—Hemostasis—IL3—bone cancer	0.000144	0.0013	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—EIF2S1—bone cancer	0.000143	0.00129	CbGpPWpGaD
Menadione—NQO1—Metabolism—NDUFA12—bone cancer	0.000142	0.00128	CbGpPWpGaD
Menadione—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00014	0.00127	CbGpPWpGaD
Menadione—MTHFR—Metabolism—NDUFA12—bone cancer	0.00014	0.00126	CbGpPWpGaD
Menadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000139	0.00126	CbGpPWpGaD
Menadione—AOX1—Metabolism—NDUFA12—bone cancer	0.000137	0.00123	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—ATF1—bone cancer	0.000133	0.0012	CbGpPWpGaD
Menadione—F10—Hemostasis—SPARC—bone cancer	0.000133	0.00119	CbGpPWpGaD
Menadione—MTHFR—Folate Metabolism—TP53—bone cancer	0.000132	0.00119	CbGpPWpGaD
Menadione—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000132	0.00118	CbGpPWpGaD
Menadione—F2—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000131	0.00118	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—GRM1—bone cancer	0.00013	0.00117	CbGpPWpGaD
Menadione—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000128	0.00115	CbGpPWpGaD
Menadione—F7—Hemostasis—PLAU—bone cancer	0.000128	0.00115	CbGpPWpGaD
Menadione—XDH—Metabolism—NDUFA12—bone cancer	0.000127	0.00114	CbGpPWpGaD
Menadione—F2—Selenium Micronutrient Network—PTGS2—bone cancer	0.000122	0.0011	CbGpPWpGaD
Menadione—F10—Hemostasis—GNA11—bone cancer	0.000121	0.00109	CbGpPWpGaD
Menadione—NQO1—Metabolism—NT5C3A—bone cancer	0.000117	0.00106	CbGpPWpGaD
Menadione—MTHFR—Metabolism—NT5C3A—bone cancer	0.000116	0.00104	CbGpPWpGaD
Menadione—PROZ—Metabolism of proteins—MMP2—bone cancer	0.000115	0.00104	CbGpPWpGaD
Menadione—MAOB—Metabolism—NDUFA12—bone cancer	0.000115	0.00104	CbGpPWpGaD
Menadione—AOX1—Metabolism—NT5C3A—bone cancer	0.000113	0.00102	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—TUBB4B—bone cancer	0.000112	0.00101	CbGpPWpGaD
Menadione—F10—Hemostasis—IL3—bone cancer	0.00011	0.00099	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—EIF2S1—bone cancer	0.000109	0.000985	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000108	0.000975	CbGpPWpGaD
Menadione—F7—Circadian rythm related genes—TP53—bone cancer	0.000107	0.000967	CbGpPWpGaD
Menadione—PROC—Hemostasis—PLAU—bone cancer	0.000107	0.000963	CbGpPWpGaD
Menadione—XDH—Metabolism—NT5C3A—bone cancer	0.000105	0.000948	CbGpPWpGaD
Menadione—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000103	0.000932	CbGpPWpGaD
Menadione—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000102	0.00092	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	9.88e-05	0.00089	CbGpPWpGaD
Menadione—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	9.78e-05	0.000881	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—TUBB2A—bone cancer	9.65e-05	0.00087	CbGpPWpGaD
Menadione—MAOB—Metabolism—NT5C3A—bone cancer	9.56e-05	0.000861	CbGpPWpGaD
Menadione—PROS1—Hemostasis—PLAU—bone cancer	9.46e-05	0.000853	CbGpPWpGaD
Menadione—CYP2A6—Biological oxidations—CYP3A4—bone cancer	9.38e-05	0.000845	CbGpPWpGaD
Menadione—CYP2A6—Fluoropyrimidine Activity—TP53—bone cancer	9.26e-05	0.000835	CbGpPWpGaD
Menadione—CYP1A1—Tryptophan metabolism—MDM2—bone cancer	9.22e-05	0.000831	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—TGFBR2—bone cancer	9.14e-05	0.000824	CbGpPWpGaD
Menadione—CYP2A6—NRF2 pathway—GSTP1—bone cancer	9.14e-05	0.000824	CbGpPWpGaD
Menadione—F2—GPCR ligand binding—SMO—bone cancer	9.13e-05	0.000823	CbGpPWpGaD
Menadione—F2—Folate Metabolism—TP53—bone cancer	9.11e-05	0.000821	CbGpPWpGaD
Menadione—F9—Metabolism of proteins—MMP2—bone cancer	9.01e-05	0.000812	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	8.89e-05	0.000801	CbGpPWpGaD
Menadione—GGCX—Metabolism of proteins—MMP2—bone cancer	8.51e-05	0.000767	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—GRM4—bone cancer	8.45e-05	0.000761	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—RGS1—bone cancer	8.45e-05	0.000761	CbGpPWpGaD
Menadione—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	8.39e-05	0.000756	CbGpPWpGaD
Menadione—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	8.32e-05	0.000749	CbGpPWpGaD
Menadione—F2—Hemostasis—SPARC—bone cancer	8.16e-05	0.000736	CbGpPWpGaD
Menadione—CYP2A6—Biological oxidations—GSTP1—bone cancer	8.02e-05	0.000723	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	8.02e-05	0.000722	CbGpPWpGaD
Menadione—F7—Metabolism of proteins—MMP2—bone cancer	7.91e-05	0.000713	CbGpPWpGaD
Menadione—PROS1—Immune System—ATF1—bone cancer	7.76e-05	0.000699	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—RGS1—bone cancer	7.67e-05	0.000691	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—GRM4—bone cancer	7.67e-05	0.000691	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—KIT—bone cancer	7.58e-05	0.000683	CbGpPWpGaD
Menadione—PROS1—Immune System—IL3—bone cancer	7.57e-05	0.000682	CbGpPWpGaD
Menadione—F2—Hemostasis—GNA11—bone cancer	7.47e-05	0.000673	CbGpPWpGaD
Menadione—CYP2E1—Biological oxidations—CYP3A4—bone cancer	7.41e-05	0.000668	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—GRM1—bone cancer	7.32e-05	0.00066	CbGpPWpGaD
Menadione—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	7.31e-05	0.000658	CbGpPWpGaD
Menadione—F10—Hemostasis—PLAU—bone cancer	7.21e-05	0.00065	CbGpPWpGaD
Menadione—VKORC1—Metabolism of proteins—MMP2—bone cancer	7.05e-05	0.000636	CbGpPWpGaD
Menadione—CYP1A1—Biological oxidations—CYP3A4—bone cancer	6.99e-05	0.000629	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	6.9e-05	0.000621	CbGpPWpGaD
Menadione—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	6.89e-05	0.000621	CbGpPWpGaD
Menadione—F2—Hemostasis—IL3—bone cancer	6.77e-05	0.00061	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—EIF2S1—bone cancer	6.73e-05	0.000607	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—GRM1—bone cancer	6.65e-05	0.000599	CbGpPWpGaD
Menadione—PROC—Metabolism of proteins—MMP2—bone cancer	6.63e-05	0.000598	CbGpPWpGaD
Menadione—CYP1A2—Phase II conjugation—GSTP1—bone cancer	6.51e-05	0.000587	CbGpPWpGaD
Menadione—CYP2E1—Biological oxidations—GSTP1—bone cancer	6.34e-05	0.000571	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	6.3e-05	0.000568	CbGpPWpGaD
Menadione—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	6.3e-05	0.000568	CbGpPWpGaD
Menadione—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	6.25e-05	0.000563	CbGpPWpGaD
Menadione—MTHFR—Disease—ENO2—bone cancer	6.06e-05	0.000546	CbGpPWpGaD
Menadione—CYP1A1—Biological oxidations—GSTP1—bone cancer	5.97e-05	0.000538	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—MDM2—bone cancer	5.97e-05	0.000538	CbGpPWpGaD
Menadione—AOX1—Disease—ENO2—bone cancer	5.92e-05	0.000533	CbGpPWpGaD
Menadione—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	5.89e-05	0.000531	CbGpPWpGaD
Menadione—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	5.88e-05	0.00053	CbGpPWpGaD
Menadione—PROS1—Metabolism of proteins—MMP2—bone cancer	5.87e-05	0.000529	CbGpPWpGaD
Menadione—F9—Hemostasis—TP53—bone cancer	5.84e-05	0.000526	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	5.67e-05	0.000511	CbGpPWpGaD
Menadione—F2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	5.65e-05	0.000509	CbGpPWpGaD
Menadione—MTHFR—Disease—DHFR—bone cancer	5.62e-05	0.000506	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—NDUFA12—bone cancer	5.62e-05	0.000506	CbGpPWpGaD
Menadione—AOX1—Disease—DHFR—bone cancer	5.49e-05	0.000495	CbGpPWpGaD
Menadione—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	5.3e-05	0.000478	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—JUN—bone cancer	5.19e-05	0.000468	CbGpPWpGaD
Menadione—NQO1—Metabolism—ENO2—bone cancer	5.14e-05	0.000463	CbGpPWpGaD
Menadione—F7—Hemostasis—TP53—bone cancer	5.13e-05	0.000462	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	5.11e-05	0.000461	CbGpPWpGaD
Menadione—MTHFR—Metabolism—ENO2—bone cancer	5.07e-05	0.000457	CbGpPWpGaD
Menadione—AOX1—Metabolism—ENO2—bone cancer	4.96e-05	0.000447	CbGpPWpGaD
Menadione—NQO1—Metabolism—DHFR—bone cancer	4.77e-05	0.000429	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—GNA11—bone cancer	4.72e-05	0.000425	CbGpPWpGaD
Menadione—MTHFR—Metabolism—DHFR—bone cancer	4.71e-05	0.000424	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—SMO—bone cancer	4.69e-05	0.000422	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—NT5C3A—bone cancer	4.66e-05	0.00042	CbGpPWpGaD
Menadione—XDH—Metabolism—ENO2—bone cancer	4.61e-05	0.000415	CbGpPWpGaD
Menadione—AOX1—Metabolism—DHFR—bone cancer	4.6e-05	0.000414	CbGpPWpGaD
Menadione—F2—Signaling Pathways—RGS1—bone cancer	4.53e-05	0.000408	CbGpPWpGaD
Menadione—F2—Signaling Pathways—GRM4—bone cancer	4.53e-05	0.000408	CbGpPWpGaD
Menadione—F10—Metabolism of proteins—MMP2—bone cancer	4.47e-05	0.000403	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—CYP3A4—bone cancer	4.45e-05	0.000401	CbGpPWpGaD
Menadione—NQO1—Metabolism—GNA11—bone cancer	4.45e-05	0.000401	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—NDUFA12—bone cancer	4.44e-05	0.0004	CbGpPWpGaD
Menadione—F2—Hemostasis—PLAU—bone cancer	4.44e-05	0.0004	CbGpPWpGaD
Menadione—PROS1—Immune System—KIT—bone cancer	4.42e-05	0.000398	CbGpPWpGaD
Menadione—MTHFR—Metabolism—GNA11—bone cancer	4.4e-05	0.000396	CbGpPWpGaD
Menadione—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	4.39e-05	0.000396	CbGpPWpGaD
Menadione—PROC—Hemostasis—TP53—bone cancer	4.3e-05	0.000387	CbGpPWpGaD
Menadione—AOX1—Metabolism—GNA11—bone cancer	4.3e-05	0.000387	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—GNA11—bone cancer	4.29e-05	0.000386	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—IL3—bone cancer	4.28e-05	0.000385	CbGpPWpGaD
Menadione—XDH—Metabolism—DHFR—bone cancer	4.27e-05	0.000385	CbGpPWpGaD
Menadione—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	4.22e-05	0.00038	CbGpPWpGaD
Menadione—MAOB—Metabolism—ENO2—bone cancer	4.19e-05	0.000377	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NDUFA12—bone cancer	4.19e-05	0.000377	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—EGFR—bone cancer	4.08e-05	0.000368	CbGpPWpGaD
Menadione—MTHFR—Disease—TGFBR2—bone cancer	4.07e-05	0.000367	CbGpPWpGaD
Menadione—NQO1—Metabolism—CYP3A4—bone cancer	4.04e-05	0.000364	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.02e-05	0.000362	CbGpPWpGaD
Menadione—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.02e-05	0.000362	CbGpPWpGaD
Menadione—XDH—Metabolism—GNA11—bone cancer	3.99e-05	0.00036	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CYP3A4—bone cancer	3.99e-05	0.000359	CbGpPWpGaD
Menadione—AOX1—Disease—TGFBR2—bone cancer	3.98e-05	0.000358	CbGpPWpGaD
Menadione—F2—Signaling Pathways—GRM1—bone cancer	3.93e-05	0.000354	CbGpPWpGaD
Menadione—AOX1—Metabolism—CYP3A4—bone cancer	3.9e-05	0.000351	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL3—bone cancer	3.89e-05	0.00035	CbGpPWpGaD
Menadione—MAOB—Metabolism—DHFR—bone cancer	3.88e-05	0.00035	CbGpPWpGaD
Menadione—CYP1A2—Biological oxidations—GSTP1—bone cancer	3.81e-05	0.000343	CbGpPWpGaD
Menadione—PROS1—Hemostasis—TP53—bone cancer	3.8e-05	0.000343	CbGpPWpGaD
Menadione—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	3.76e-05	0.000339	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—NT5C3A—bone cancer	3.68e-05	0.000332	CbGpPWpGaD
Menadione—MAOB—Metabolism—GNA11—bone cancer	3.63e-05	0.000327	CbGpPWpGaD
Menadione—XDH—Metabolism—CYP3A4—bone cancer	3.62e-05	0.000326	CbGpPWpGaD
Menadione—PROS1—Immune System—MDM2—bone cancer	3.48e-05	0.000313	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—NT5C3A—bone cancer	3.47e-05	0.000313	CbGpPWpGaD
Menadione—NQO1—Metabolism—GSTP1—bone cancer	3.45e-05	0.000311	CbGpPWpGaD
Menadione—MTHFR—Metabolism—GSTP1—bone cancer	3.41e-05	0.000307	CbGpPWpGaD
Menadione—AOX1—Metabolism—GSTP1—bone cancer	3.33e-05	0.0003	CbGpPWpGaD
Menadione—MAOB—Metabolism—CYP3A4—bone cancer	3.29e-05	0.000297	CbGpPWpGaD
Menadione—XDH—Metabolism—GSTP1—bone cancer	3.1e-05	0.000279	CbGpPWpGaD
Menadione—PROS1—Immune System—JUN—bone cancer	3.02e-05	0.000272	CbGpPWpGaD
Menadione—F10—Hemostasis—TP53—bone cancer	2.9e-05	0.000261	CbGpPWpGaD
Menadione—MAOB—Metabolism—GSTP1—bone cancer	2.82e-05	0.000254	CbGpPWpGaD
Menadione—MTHFR—Disease—KIT—bone cancer	2.78e-05	0.00025	CbGpPWpGaD
Menadione—F2—Signaling Pathways—SMO—bone cancer	2.77e-05	0.000249	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—MMP2—bone cancer	2.75e-05	0.000248	CbGpPWpGaD
Menadione—AOX1—Disease—KIT—bone cancer	2.71e-05	0.000245	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NDUFA12—bone cancer	2.67e-05	0.000241	CbGpPWpGaD
Menadione—MTHFR—Disease—BRAF—bone cancer	2.61e-05	0.000235	CbGpPWpGaD
Menadione—AOX1—Disease—BRAF—bone cancer	2.55e-05	0.00023	CbGpPWpGaD
Menadione—F2—Signaling Pathways—GNA11—bone cancer	2.53e-05	0.000228	CbGpPWpGaD
Menadione—PROS1—Immune System—EGFR—bone cancer	2.38e-05	0.000214	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ATF1—bone cancer	2.35e-05	0.000212	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL3—bone cancer	2.3e-05	0.000207	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NT5C3A—bone cancer	2.21e-05	0.000199	CbGpPWpGaD
Menadione—MTHFR—Disease—MDM2—bone cancer	2.19e-05	0.000197	CbGpPWpGaD
Menadione—AOX1—Disease—MDM2—bone cancer	2.14e-05	0.000193	CbGpPWpGaD
Menadione—MTHFR—Disease—PTGS2—bone cancer	2.11e-05	0.00019	CbGpPWpGaD
Menadione—AOX1—Disease—PTGS2—bone cancer	2.06e-05	0.000186	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ENO2—bone cancer	2.04e-05	0.000184	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TGFBR2—bone cancer	1.96e-05	0.000177	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—DHFR—bone cancer	1.89e-05	0.000171	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IGF1R—bone cancer	1.85e-05	0.000166	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTGS2—bone cancer	1.79e-05	0.000161	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—bone cancer	1.79e-05	0.000161	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—GNA11—bone cancer	1.77e-05	0.000159	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTGS2—bone cancer	1.77e-05	0.000159	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTGS2—bone cancer	1.73e-05	0.000156	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ENO2—bone cancer	1.61e-05	0.000145	CbGpPWpGaD
Menadione—XDH—Metabolism—PTGS2—bone cancer	1.6e-05	0.000145	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP3A4—bone cancer	1.6e-05	0.000144	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ENO2—bone cancer	1.52e-05	0.000137	CbGpPWpGaD
Menadione—MTHFR—Disease—EGFR—bone cancer	1.5e-05	0.000135	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—DHFR—bone cancer	1.5e-05	0.000135	CbGpPWpGaD
Menadione—AOX1—Disease—EGFR—bone cancer	1.46e-05	0.000132	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTGS2—bone cancer	1.46e-05	0.000131	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—DHFR—bone cancer	1.41e-05	0.000127	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GNA11—bone cancer	1.4e-05	0.000126	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—GSTP1—bone cancer	1.37e-05	0.000124	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KIT—bone cancer	1.34e-05	0.000121	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GNA11—bone cancer	1.32e-05	0.000119	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP3A4—bone cancer	1.27e-05	0.000114	CbGpPWpGaD
Menadione—F2—Signaling Pathways—BRAF—bone cancer	1.26e-05	0.000113	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—EGFR—bone cancer	1.22e-05	0.00011	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP3A4—bone cancer	1.19e-05	0.000108	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.19e-05	0.000107	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—GSTP1—bone cancer	1.08e-05	9.76e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MDM2—bone cancer	1.05e-05	9.5e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—GSTP1—bone cancer	1.02e-05	9.21e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ENO2—bone cancer	9.69e-06	8.73e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—JUN—bone cancer	9.17e-06	8.26e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—DHFR—bone cancer	8.99e-06	8.1e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MMP9—bone cancer	8.92e-06	8.04e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GNA11—bone cancer	8.4e-06	7.57e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP3A4—bone cancer	7.62e-06	6.86e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.58e-06	6.83e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EGFR—bone cancer	7.21e-06	6.49e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTGS2—bone cancer	7.1e-06	6.4e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—GSTP1—bone cancer	6.52e-06	5.87e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—bone cancer	6.05e-06	5.45e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTGS2—bone cancer	5.61e-06	5.06e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTGS2—bone cancer	5.29e-06	4.77e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTGS2—bone cancer	3.38e-06	3.04e-05	CbGpPWpGaD
